ProducsProprietary Products

Glassia

Therapeutic indication:

GLASSIA, is an Alpha1 -Proteinase Inhibitor (Human), indicated for chronic augmentation and maintenance therapy in individuals with clinically evident emphysema due to severe hereditary deficiency of Alpha1 -PI, also known as alpha1 -antitrypsin (AAT) deficiency. GLASSIA increases antigenic and functional (anti-neutrophil elastase capacity, ANEC) serum levels and antigenic lung epithelial lining fluid levels of Alpha1 -PI.

  • Composition: Alpha1-Proteinase Inhibitor (Human)
  • Pharmaceutical form: solution for infusion
  • Method of administration: intravenous (Ready-to-administer)
  • Manufacturer: Kamada